February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...
The application is supported by data from a phase 3 trial (ClinicalTrials.gov Identifier: NCT04502693) in which study participants received 2 doses of MenABCWY administered 6 months apart or 2 doses ...
Findings showed MenABCWY met the primary endpoint demonstrating noninferiority to 2 doses of Bexsero and 1 dose of Menveo for all 5 Neisseria meningitidis serogroups (A, B, C, W and Y).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback